Carolyn S Dewa1, Angus H Thompson, Phillip Jacobs. 1. Centre for Research on Employment and Workplace Health, Centre for Addiction and Mental Health, Toronto, Ontario. carolyn_dewa@camh.net
Abstract
OBJECTIVE: About one-third of the annual $51 billion cost of mental illnesses is related to productivity losses. However, few studies have examined the association of treatment and productivity. The purpose of our research is to examine the association of depression and its treatment and work productivity. METHODS: Our analyses used data from 2737 adults aged between 18 and 65 years who participated in a large-scale community survey of employed and recently employed people in Alberta. Using the World Health Organization's Health and Work Performance Questionnaire, a productivity variable was created to capture high productivity (above the 75th percentile). We used regression methods to examine the association of mental disorders and their treatment and productivity, controlling for demographic factors and job characteristics. RESULTS: In the sample, about 8.5% experienced a depressive episode in the past year. The regression results indicated that people who had a severe depressive episode were significantly less likely to be highly productive. Compared with people who had a moderate or severe depressive episode who did not have treatment, those who did have treatment were significantly more likely to be highly productive. However, about one-half of workers with a moderate or severe depressive episode did not receive treatment. CONCLUSIONS: Our results corroborate those in the literature that indicate mental disorders are significantly associated with decreased work productivity. In addition, these findings indicate that treatment for these disorders is significantly associated with productivity. Our results also highlight the low proportion of workers with a mental disorder who receive treatment.
OBJECTIVE: About one-third of the annual $51 billion cost of mental illnesses is related to productivity losses. However, few studies have examined the association of treatment and productivity. The purpose of our research is to examine the association of depression and its treatment and work productivity. METHODS: Our analyses used data from 2737 adults aged between 18 and 65 years who participated in a large-scale community survey of employed and recently employed people in Alberta. Using the World Health Organization's Health and Work Performance Questionnaire, a productivity variable was created to capture high productivity (above the 75th percentile). We used regression methods to examine the association of mental disorders and their treatment and productivity, controlling for demographic factors and job characteristics. RESULTS: In the sample, about 8.5% experienced a depressive episode in the past year. The regression results indicated that people who had a severe depressive episode were significantly less likely to be highly productive. Compared with people who had a moderate or severe depressive episode who did not have treatment, those who did have treatment were significantly more likely to be highly productive. However, about one-half of workers with a moderate or severe depressive episode did not receive treatment. CONCLUSIONS: Our results corroborate those in the literature that indicate mental disorders are significantly associated with decreased work productivity. In addition, these findings indicate that treatment for these disorders is significantly associated with productivity. Our results also highlight the low proportion of workers with a mental disorder who receive treatment.
Authors: Raymond W Lam; Diane McIntosh; JianLi Wang; Murray W Enns; Theo Kolivakis; Erin E Michalak; Jitender Sareen; Wei-Yi Song; Sidney H Kennedy; Glenda M MacQueen; Roumen V Milev; Sagar V Parikh; Arun V Ravindran Journal: Can J Psychiatry Date: 2016-08-02 Impact factor: 4.356
Authors: Ron Z Goetzel; Enid Chung Roemer; Calliope Holingue; M Daniele Fallin; Katherine McCleary; William Eaton; Jacqueline Agnew; Francisca Azocar; David Ballard; John Bartlett; Michael Braga; Heidi Conway; K Andrew Crighton; Richard Frank; Kim Jinnett; Debra Keller-Greene; Sara Martin Rauch; Richard Safeer; Dick Saporito; Anita Schill; David Shern; Victor Strecher; Peter Wald; Philip Wang; C Richard Mattingly Journal: J Occup Environ Med Date: 2018-04 Impact factor: 2.162
Authors: Vanessa C Evans; Golnoush Alamian; Jane McLeod; Cindy Woo; Lakshmi N Yatham; Raymond W Lam Journal: CNS Drugs Date: 2016-05 Impact factor: 5.749
Authors: Robyn Considine; Ross Tynan; Carole James; John Wiggers; Terry Lewin; Kerry Inder; David Perkins; Tonelle Handley; Brian Kelly Journal: PLoS One Date: 2017-01-03 Impact factor: 3.240
Authors: Ann John; Joanne McGregor; David Fone; Frank Dunstan; Rosie Cornish; Ronan A Lyons; Keith R Lloyd Journal: BMC Med Inform Decis Mak Date: 2016-03-15 Impact factor: 2.796